Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1682 1683 1693
This examiner grants 63% of resolved cases
Allison Elizabeth Schloop serves as an examiner in Tech Center 1600 and Art Unit 1682. She has 46 resolved cases in her record. The allowance rate for these applications is 63.0 percent. This 63.0 percent figure indicates the proportion of cases that reach a successful conclusion. Practitioners can use the 46 resolved cases to evaluate the examiner's historical patterns.
The data shows an interview lift of 56.5 percent. This 56.5 percent value measures the increase in allowance probability when an interview is performed. A positive lift of 56.5 percent suggests that oral discussions are a highly effective tool for advancing prosecution. Applicants should consider this statistic when deciding whether to engage with the examiner directly.
The median days to allowance is 1448. This 1448-day period represents the typical length of time from filing to a patent grant. For those in Art Unit 1682, this 1448-day median is a primary indicator of the expected prosecution timeline. The 63.0 percent allowance rate and the 1448-day median provide a comprehensive view of the results in this docket.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18405884 | METHODS AND COMPOSITIONS FOR IN SITU ANALYSIS OF VARIANT SEQUENCES | Non-Final OA | 10x Genomics, Inc. |
| 17915167 | METHODS OF PROFILING TRANSLATION RATE | Final Rejection | The Regents of the University of California |
| 18280164 | NUCLEIC ACID DETECTION AND ANALYSIS SYSTEMS | Non-Final OA | The Johns Hopkins University |
| 18050809 | PAPANICOLAOU TEST FOR OVARIAN AND ENDOMETRIAL CANCERS | Non-Final OA | The Johns Hopkins University |
| 17771772 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ESOPHAGEAL CANCER | Final Rejection | THE JOHNS HOPKINS UNIVERSITY |
| 17683246 | SAME-SAMPLE ANTIBIOTIC SUSCEPTIBILITY TEST AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | Non-Final OA | CALIFORNIA INSTITUTE OF TECHNOLOGY |
| 19240318 | NEOANTIGEN IMMUNOTHERAPY | Final Rejection | Gradalis, Inc. |
| 17560724 | COMPOSITIONS AND METHODS FOR DETECTION OF BACTERIA AND FUNGI ASSOCIATED WITH BACTERIAL AND CANDIDA VAGINOSIS | Final Rejection | Roche Molecular Systems, Inc. |
| 18051619 | SYSTEMS AND METHODS FOR USING TRAPPED CHARGE FOR BILAYER FORMATION AND PORE INSERTION IN A NANOPORE ARRAY | Non-Final OA | Roche Sequencing Solutions, Inc. |
| 17760033 | COMPOSITIONS AND METHODS FOR RAPID RNA-ADENYLATION AND RNA SEQUENCING | Final Rejection | Cornell University |
| 17863808 | METHOD FOR SYNCHRONOUSLY SEQUENCING SENSE STRAND AND ANTISENSE STRAND OF DNA | Final Rejection | MGI TECH CO., LTD. |
| 17957643 | SEQUENCING OF VIRAL DNA FOR PREDICTING DISEASE RELAPSE | Final Rejection | GRAIL, Inc. |
| 18373441 | GENE SPECIFIC TISSUE INFORMATION AND SEQUENCING | Final Rejection | Miltenyi Biotec B.V. & Co. KG |
| 17625333 | METHODS OF DETECTING DISEASE AND TREATMENT RESPONSE IN cfDNA | Non-Final OA | THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE |
| 18260011 | TRANSCRIPTION FACTOR BINDING SITE ANALYSIS OF NUCLEOSOME DEPLETED CIRCULATING CELL FREE CHROMATIN FRAGMENTS | Non-Final OA | Belgian Volition SRL (BE/BE) |
| 18315025 | METHODS AND SYSTEMS FOR SAMPLE NORMALIZATION | Non-Final OA | AccuraGen Holdings Limited |
| 18054676 | CELL-FREE DNA SIZE DETECTION | Final Rejection | AccuraGen Holdings Limited |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy